Authors:
Prochazkova, A
Liu, SL
Friess, H
Aebi, S
Thormann, W
Citation: A. Prochazkova et al., Determination of 5-fluorouracil and 5-fluoro-2 '-deoxyuridine-5 '-monophosphate in pancreatic cancer cell line and other biological materials using capillary electrophoresis, J CHROMAT A, 916(1-2), 2001, pp. 215-224
Authors:
Novak, U
Grob, TJ
Baskaynak, G
Peters, UR
Aebi, S
Zwahlen, D
Tschan, MP
Kreuzer, KA
Leibundgut, EO
Cajot, JF
Tobler, A
Fey, MF
Citation: U. Novak et al., Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia, ANN ONCOL, 12(7), 2001, pp. 981-986
Citation: B. Cenni et al., Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway, CANC CHEMOT, 47(5), 2001, pp. 397-403
Authors:
Rauch, DP
Maurer, CA
Aebi, S
Pampallona, S
Friess, H
Ludwig, CU
Buchler, MW
Borner, MM
Citation: Dp. Rauch et al., Activity of gemcitabine and continuous infusion fluorouracil in advanced pancreatic cancer, ONCOL-BASEL, 60(1), 2001, pp. 43-48
Authors:
Xu, ZW
Friess, H
Solioz, M
Aebi, S
Korc, M
Kleeff, J
Buchler, MW
Citation: Zw. Xu et al., Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine, INT J CANC, 94(2), 2001, pp. 268-274
Authors:
Pabst, T
Peters, UR
Tinguely, M
Schwaller, J
Tschan, M
Aebi, S
Vonlanthen, S
Borisch, B
Betticher, DC
Zimmermann, A
Tobler, A
Fey, MF
Citation: T. Pabst et al., Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14(ARF) /p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia, LEUK LYMPH, 37(5-6), 2000, pp. 639-648
Authors:
Balli, S
Fey, MF
Hanggi, W
Zwahlen, D
Berclaz, G
Dreher, E
Aebi, S
Citation: S. Balli et al., Ovarian cancer: an institutional review of patterns of care, health insurance and prognosis, EUR J CANC, 36(16), 2000, pp. 2061-2068
Authors:
de las Alas, MM
Christen, RD
Gately, DP
Weiner, DE
Benbatoul, K
Kirmani, S
D'Agostino, HR
Plaxe, SC
Darrah, D
McClay, EF
Aebi, S
Howell, SB
Los, G
Citation: Mm. De Las Alas et al., Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel, CANC CHEMOT, 45(5), 2000, pp. 381-388
Authors:
Aebi, S
Gelber, S
Castiglione-Gertsch, M
Gelber, RD
Collins, J
Thurlimann, B
Rudenstam, CM
Lindtner, J
Crivellari, D
Cortes-Funes, H
Simoncini, E
Werner, ID
Coates, AS
Goldhirsch, A
Citation: S. Aebi et al., Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?, LANCET, 355(9218), 2000, pp. 1869-1874
Authors:
Zwahlen, D
Tschan, MP
Grob, TJ
Peters, UR
Fink, D
Haenggi, W
Altermatt, HJ
Cajot, JF
Tobler, A
Fey, MF
Aebi, S
Citation: D. Zwahlen et al., Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours, INT J CANC, 88(1), 2000, pp. 66-70
Authors:
Zahnd, D
Aebi, S
Rusterholz, S
Fey, MF
Borner, MM
Citation: D. Zahnd et al., A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices, ANN ONCOL, 10(6), 1999, pp. 727-729
Authors:
Aebi, S
Schnider, TW
Los, G
Heath, DD
Darrah, D
Kirmani, S
McClay, EF
D'Agostino, H
Plaxe, SC
Fink, D
De las Alas, MM
Howell, SB
Christen, RD
Citation: S. Aebi et al., A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel, CANC CHEMOT, 44(3), 1999, pp. 259-265
Authors:
Cenni, B
Kim, HK
Bubley, GJ
Aebi, S
Fink, D
Teicher, BA
Howell, S
Christen, RD
Citation: B. Cenni et al., Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin, BR J CANC, 80(5-6), 1999, pp. 699-704